Cécile Leyronnas

863 total citations
4 papers, 22 citations indexed

About

Cécile Leyronnas is a scholar working on Pathology and Forensic Medicine, Oncology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Cécile Leyronnas has authored 4 papers receiving a total of 22 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pathology and Forensic Medicine, 3 papers in Oncology and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Cécile Leyronnas's work include Chemotherapy-induced cardiotoxicity and mitigation (2 papers), Neutropenia and Cancer Infections (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). Cécile Leyronnas is often cited by papers focused on Chemotherapy-induced cardiotoxicity and mitigation (2 papers), Neutropenia and Cancer Infections (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). Cécile Leyronnas collaborates with scholars based in France. Cécile Leyronnas's co-authors include Michel Tod, Claire Falandry, Jean-Michel Vannetzel, David Assouline, Gilles Freyer, Catherine Ligeza‐Poisson, David Coeffic, Alexandre Sostelly, Anne‐Claire Hardy‐Bessard and Émilie Hénin and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Haematology and Annals of Hematology.

In The Last Decade

Cécile Leyronnas

4 papers receiving 22 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cécile Leyronnas France	3	14	7	5	4	4	4	22
Eid Hanna Hungary	2	10 0.7×	5 0.7×	5 1.0×		2 0.5×	6	25
Clara Maluquer Spain	3	9 0.6×	3 0.4×	8 1.6×		5 1.3×	10	27
Katrina Kao United States	2	12 0.9×	9 1.3×	4 0.8×			2	21
Carmen Martínez Chamorro Spain	3	11 0.8×	11 1.6×	10 2.0×			6	18
Neil Dalal United States	3	9 0.6×	7 1.0×	4 0.8×		1 0.3×	9	31
Daryl Ming Zhe Cheah Singapore	2	9 0.6×	13 1.9×	5 1.0×			3	15
Alexander Wald Germany	3	10 0.7×	6 0.9×	4 0.8×			8	22
Rim S. Kim United States	4	22 1.6×	5 0.7×	2 0.4×			7	25
Giovanni Paolo Maria Zambrotta Italy	2	9 0.6×	9 1.3×	3 0.6×			4	15
J Kryński Poland	3	15 1.1×	3 0.4×	3 0.6×			6	23

Countries citing papers authored by Cécile Leyronnas

Since Specialization

Citations

This map shows the geographic impact of Cécile Leyronnas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cécile Leyronnas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cécile Leyronnas more than expected).

Fields of papers citing papers by Cécile Leyronnas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cécile Leyronnas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cécile Leyronnas. The network helps show where Cécile Leyronnas may publish in the future.

Co-authorship network of co-authors of Cécile Leyronnas

This figure shows the co-authorship network connecting the top 25 collaborators of Cécile Leyronnas. A scholar is included among the top collaborators of Cécile Leyronnas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cécile Leyronnas. Cécile Leyronnas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

1.

Cristante, Justine, Bruno Tesson, Frédérique Orsini‐Piocelle, et al.. (2021). Adverse outcome in follicular lymphoma is associated with MYC rearrangements but not MYC extra copies. British Journal of Haematology. 194(2). 382–392. 7 indexed citations

2.

Sostelly, Alexandre, Émilie Hénin, L. Chauvenet, et al.. (2012). Can we predict chemo-induced hematotoxicity in elderly patients treated with pegylated liposomal doxorubicin? Results of a population-based model derived from the DOGMES phase II trial of the GINECO. Journal of Geriatric Oncology. 4(1). 48–57. 10 indexed citations

3.

Coeffic, David, Carolina Castillo, Catherine Sebban, et al.. (2010). Use of chemotherapy and immunotherapy in the last two months of life in a French institutional anticancer center, 2008-2009.. Journal of Clinical Oncology. 28(15_suppl). e19656–e19656. 1 indexed citations

4.

Page, E, David Assouline, Catherine Durand, et al.. (2006). Stage-related changes in functional capacity in Hodgkin’s disease: assessment by cardiopulmonary exercise testing before initiation of treatment. Annals of Hematology. 85(12). 857–861. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact